Product code PQP
- Device name
- Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
- Medical specialty
- Unknown
- Device class
- 3
- Review panel
- PA
- Implant
- N
- Life sustaining/supporting
- N
- GMP exempt
- N
- Third party review
- N
- Summary malfunction reporting
- Eligible
- Definition
- A next generation sequencing (NGS) oncology panel is a device used for the qualitative detection of germline or somatic variants in one or more cancer-related genes. The device is intended to be used on DNA or RNA isolated from human clinical specimens.
- Source
- FDA openFDA device classification dataset
Related PMA Records#
| PMA | Device | Applicant | Decision date |
|---|---|---|---|
| P250027 | Guardant360® Liquid CDx | Guardant Health, Inc. | 2026-05-19 |
| P260004 | Signatera™ CDx | Natera, Inc. | 2026-05-15 |
| P170019S067 | FoundationOne CDx | Foundation Medicine, Inc. | 2026-05-12 |
| P190032S025 | FoundationOne®Liquid CDx | Foundation Medicine, Inc. | 2026-05-08 |
| P170019S059 | FoundationOne® CDx | Foundation Medicine, Inc. | 2026-05-08 |
| P200010S025 | Guardant360® CDx | Guardant Health, Inc. | 2026-05-01 |
| P230011S007 | TruSight Oncology Comprehensive | Illumina, Inc. | 2026-04-23 |
| P160045S052 | Oncomine™ Dx Target Test | Life Technologies Corporation | 2026-03-04 |
| P200010S026 | Guardant360 CDx | Guardant Health, Inc. | 2026-01-15 |
| P200010S028 | Guardant360 CDx | Guardant Health, Inc. | 2025-12-29 |
| P160045S051 | Oncomine™ Dx Target Test | Life Technologies Corporation | 2025-11-21 |
| P160045S050 | Oncomine Dx Target Test | Life Technologies Corporation | 2025-11-19 |
| P240040S003 | Oncomine Dx Express Test | Life Technologies Corporation | 2025-10-22 |
| P240040S002 | Oncomine Dx Express Test | Life Technologies Corporation | 2025-10-15 |
| P200010S021 | Guardant360 CDx | Guardant Health, Inc. | 2025-09-25 |
| P230011S005 | TruSight Oncology Comprehensive | Illumina, Inc. | 2025-09-19 |
| P230011S004 | TruSight Oncology Comprehensive | Illumina, Inc. | 2025-09-05 |
| P160045S049 | Oncomine Dx Target Test | Life Technologies Corporation | 2025-08-08 |
| P240040S001 | Oncomine™ Dx Express Test | Life Technologies Corporation | 2025-08-07 |
| P240040 | Oncomine Dx Express Test | Life Technologies Corporation | 2025-07-02 |
| P210011S003 | xT CDx | Tempus Labs, Inc. | 2025-06-27 |
| P240010S005 | MI Cancer Seek | Caris Life Sciences | 2025-06-18 |
| P240010S004 | MI Cancer Seek | Caris Life Sciences | 2025-06-09 |
| P240010S003 | MI Cancer Seek | Caris Life Sciences | 2025-06-04 |
| P230011S003 | TruSight Oncology Comprehensive | Illumina, Inc. | 2025-04-18 |
| P200010S022 | Guardant360 CDx | Guardant Health, Inc. | 2025-02-07 |
| P240010S001 | MI Cancer Seek | Caris Life Sciences | 2025-02-06 |
| P200010S023 | Guardant360 CDx | Guardant Health, Inc. | 2025-01-22 |
| P170019S054 | FoundationOne CDx | Foundation Medicine, Inc. | 2025-01-16 |
| P240010S002 | MI Cancer Seek | Caris Life Sciences | 2025-01-07 |
Related GUDID Devices#
| Primary DI | Brand | Company | Published |
|---|---|---|---|
| 00860008613325 | MI Cancer Seek® | CARIS MPI, INC. | 2025-04-30 |
| 00816270020217 | TruSight™ Oncology Comprehensive | ILLUMINA, INC. | 2024-12-09 |
| 00850059806005 | Resolution ctDx FIRST Sample Collection Kit | Resolution Bioscience, Inc. | 2024-03-31 |
| 10190302017756 | Oncomine™ Dx Target Test User Guides and Assay Definition File | LIFE TECHNOLOGIES CORPORATION | 2022-01-23 |
| 00860001218282 | oncoReveal CDx | Pillar Biosciences, Inc. | 2021-09-20 |
| 00860001218275 | PiVAT Software | Pillar Biosciences, Inc. | 2021-09-20 |
| 00860001218251 | oncoReveal CDx | Pillar Biosciences, Inc. | 2021-09-20 |
| 00860001218244 | oncoReveal CDx Box 3 | Pillar Biosciences, Inc. | 2021-09-20 |
| 00860001218237 | oncoReveal CDx Box 2 | Pillar Biosciences, Inc. | 2021-09-20 |
| 00860001218220 | oncoReveal CDx | Pillar Biosciences, Inc. | 2021-09-20 |
| 10190302014335 | Oncomine™ Dx Target RNA Control Diluent | LIFE TECHNOLOGIES CORPORATION | 2021-01-14 |
| 10190302015646 | Oncomine™ Dx Target Test User Guide and Assay Definition File | LIFE TECHNOLOGIES CORPORATION | 2021-01-14 |
| 10190302015134 | Oncomine™ DX Target DNA Control v2.0 | LIFE TECHNOLOGIES CORPORATION | 2021-01-14 |
| 10190302015103 | Oncomine™ Dx Target Test | LIFE TECHNOLOGIES CORPORATION | 2019-05-22 |
| 10190302000888 | Ion Torrent | LIFE TECHNOLOGIES CORPORATION | 2018-06-28 |
| 10190302005845 | Ion Torrent | LIFE TECHNOLOGIES CORPORATION | 2018-06-28 |
| 10190302005852 | Ion Torrent | LIFE TECHNOLOGIES CORPORATION | 2018-06-28 |
| 00816270020088 | Praxis Extended RAS Panel | ILLUMINA, INC. | 2017-08-28 |
| 10190302006071 | Oncomine™ Dx Target Test User Guides and Assay Definition File | LIFE TECHNOLOGIES CORPORATION | 2017-06-27 |
| 10190302006385 | Oncomine™ Dx Target Test | LIFE TECHNOLOGIES CORPORATION | 2017-06-27 |
| 10190302006156 | Ion Torrent™ Dx No Template Control Kit | LIFE TECHNOLOGIES CORPORATION | 2017-06-27 |
| 10190302006064 | Oncomine™ Dx Target RNA Control Kit | LIFE TECHNOLOGIES CORPORATION | 2017-06-27 |
| 10190302006095 | Oncomine™ Dx Target DNA Control Kit | LIFE TECHNOLOGIES CORPORATION | 2017-06-27 |